A key event in the pathogenesis of transmissible spongiform encephalopathies is the conversion of PrP-sen to PrP-res. Morrissey and Shakhnovich (Morrissey, M. P., and Shakhnovich, E. I. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 11293-11298) proposed that the conversion mechanism involves critical interactions at helix 1 (residues 144 -153) and that the helix is stabilized on PrPsen by intra-helix salt bridges between two aspartic acid-arginine ion pairs at positions 144 and 148 and at 147 and 151, respectively. Mutants of the hamster prion protein were constructed by replacing the aspartic acids with either asparagines or alanines to destabilize the proposed helix 1 salt bridges. Thermal and chemical denaturation experiments using circular dichroism spectroscopy indicated the overall structures of the mutants are not substantially destabilized but appear to unfold differently. Cell-free conversion reactions performed using ionic denaturants, detergents, and salts (conditions unfavorable to salt bridge formation) showed no significant differences between conversion efficiencies of mutant and wild type proteins. Using conditions more favorable to salt bridge formation, the mutant proteins converted with up to 4-fold higher efficiency than the wild type protein. Thus, although spectroscopic data indicate the salt bridges do not substantially stabilize PrP-sen, the cell-free conversion data suggest that Asp-144 and Asp-147 and their respective salt bridges stabilize PrP-sen from converting to PrP-res.
scrapie in sheep, mice, and hamsters; bovine spongiform encephalopathy in cattle; and chronic wasting disease in deer and elk. PrP-res accumulates as a result of the conversion of the normal, protease-sensitive form of PrP (PrP C or PrP-sen), which occurs as a post-translational process without any apparent requirement for covalent modifications (1, 2).
Although not yet fully understood, the accumulation of PrP-res appears to lead to cerebral amyloidosis, dementia, motor dysfunction, and eventually death. PrP-res forms insoluble aggregates and is partially resistant to proteinase K (PK), which removes ϳ67 amino acid residues (6 -7 kDa) from the N terminus (1, (3) (4) (5) . These differences in biophysical properties most likely reflect different conformations of the two protein isoforms. Optical spectroscopic data indicate that PrP-sen isolated from normal brain is highly ␣-helical, whereas PrP-res contains a large proportion of ␤-sheet structure (6 -8) .
The conversion of PrP-sen into PrP-res is likely to be the key event in the pathogenesis of TSE diseases. Although TSE diseases may be sporadic, genetic, or infectious in origin, it is commonly argued that, in each circumstance, the disease propagates itself through a self-catalytic mechanism involving existing multimers of PrP-res. This idea is supported by experiments that show that PrP-res can induce the conversion of native PrP into PrP-res-like aggregates in vitro (9, 10) . However, the precise molecular mechanism of the conversion between the normal and pathogenic forms of prion proteins remains poorly understood.
Prior to conversion to PrP-res, the structure of PrP-sen (see Fig. 1 ) consists of a core domain (residues 125-228), containing three ␣-helices (helix 1, residues 144 -154; helix 2, 172-193; and helix 3, 200 -227) and two short antiparallel ␤-strands (residues 129 -131 and 161-163), and a largely unstructured N-terminal domain (residues 23-119) (11) . Several considerations (12) (13) (14) (15) suggest that helix 1 (residues 144 -153) might be a site of interaction of PrP-sen and PrP-res and that it plays a critical role in the initial stages of PrP-sen unfolding and conversion. Morrissey and Shakhnovich (12) noted that helix 1 is unusually hydrophilic and lacking in non-covalent contacts with the remainder of the protein. They proposed that the stabilization of helix 1 is self-sustaining through the presence of intra-helix electrostatic interactions such as the two properly phased Asp-Arg pairs within the helix, which form strong salt bridges and stabilize the helical turns ( Fig. 1) (12) . The directional ordering of the charges is expected to interact with the intrinsic dipole moment of the helix providing further stabilization. Molecular modeling studies suggested that the conserved amino acid sequence of hamster PrP helix 1 might favorably adopt conformations necessary to form intermolecular ␤-sheet aggregates and that these aggregates might be stabilized by intermolecular salt bridges between the helix 1 Asp and Arg residues of adjacent molecules (12) . Consistent with this idea, Vorberg et al. reported that the deletion of helix 1 from PrP-sen completely inhibited its conversion to PrP-res (31) . Other studies have shown that a de novo ␣ to ␤ conformational change and aggregation of recombinant human PrP occurs in the presence of 1 M guanidine hydrochloride (GdnHCl) and at pH levels below 5.0 (13) (14) (15) . If the non-ionic denaturant urea was used, then the ␤ conversion also required NaCl. It is possible that the protonation of Asp-144 and Asp-147 at low pH interrupts the salt bridges in helix 1 and compromises its stability. The presence of the additional denaturant and salts may also help disrupt the overall structure and stability of the folded protein and screen electrostatic charges that stabilize helix 1.
To address the question of the role of helix 1 Asp residues and their salt bridges to Arg residues in the stabilization of PrP-sen and its conversion to PrP-res, we have prepared six mutants replacing Asp-144 and Asp-147 with either asparagines or alanines to eliminate the putative salt bridges. The results indicate that PrP-sen is not substantially stabilized overall by the Asp-Arg salt bridges and that intermolecular salt bridge formation involving the same residues is not essential for the formation of PrP-res. The unfolding pathway of PrP-sen and its conversion to PrP-res, however, are influenced by interactions involving the helix 1 aspartic acid residues. These results provide insight into the basic mechanism of PrP-res formation.
EXPERIMENTAL PROCEDURES

Prokaryotic Expression of Wild Type and Mutant Hamster PrP-(23-231)-
The plasmid encoding Syrian hamster PrP (HaPrP) (residues 23-231) was constructed in a pET24a(ϩ) vector from Novagen inserted as an NdeI fragment using standard cloning techniques. Mutations at positions 144, 147, and both 144 and 147 were introduced using the QuikChange site-directed mutagenesis kit from Stratagene. Oligonucleotides used in the mutagenesis were obtained from Genosys Biotechnologies and include the following: (D144N) 5Ј-GCATTTTGGCAATA-ACTGGGAGGACCGCTACTACCG-3Ј and 5Ј-CGGTAGTAGCGGT CCTCCCAGTTATTGCCAAAATGC-3Ј; (D147N) 5Ј-GCAATGACTGGG-AGAACCGCTACTACCGTGAAAAC-3Ј and 5Ј-GTTTTCACGGTAGTA-GCGGTTCTCCCAGTCATTGC-3Ј; (D144N/D147N) 5Ј-GCATTTT GGCAATAACTGGGAGAACCGGTACTACCG-3Ј and 5Ј-CGGTAGTAG-CGGTTCTCCCAGTTATTGCCAAAATGC-3Ј. Mutant DNA was transformed into XL1-Blue supercompetent cells from Stratagene. Mutant DNA was then purified from overnight cultures using a Wizard Miniprep plasmid purification kit. All constructs were sequenced by MWG Biotech. Plasmids were transformed into BL21(DE3) supercompetent cells from Stratagene for PrP protein expression. Recombinant proteins accumulated in cytoplasmic inclusion bodies.
Eukaryotic Expression of Wild Type and Mutant
HaPrP-D-to-N mutant HaPrP (residues 23-231) in the pET24a(ϩ) vector were subcloned using Bsu36I and StuI restriction sites into full-length HaPrP without the glycosylphosphatidylinositol (GPI) anchor in a pBluescript vector generously provided by Dr. Bruce Chesebro. The D-to-A mutants were generated by site-directed mutagenesis of the HaPrP pBluescript clone using a QuikChange site-directed mutagenesis kit from Stratagene. Oligonucleotides were obtained from Genosys Biotechnologies and include the following: (D144A) 5Ј-GCATTTTGGCAATGCCTGG-GAGGACCGCTACTACCG-3Ј and 5Ј-CGGTAGTAGCGGTCCTCCCAG-GCATTGCCAAAATGC-3Ј; (D147A) 5Ј-GCAATGACTGGGAGGCCCGC TACTACCGTGAAAAC-3Ј and 5Ј-GTTTTCACGGTAGTAGCGGGCCT-CCCAGTCATTGC-3Ј; (D144A/D147A) 5Ј-GCATTTTGGCAATGCCTG-GGAGGCCCGCTACTACCG-3Ј and 5Ј-CGGTAGTAGCGGGCCTCCC-AGGCATTGCCAAAATGC-3Ј. The pBS HaPrP construct lacks the GPI anchor, because the gene lacks the C-terminal GPI attachment sequence (9) . The pBS PrP clones were then sequenced with an Applied Biosystems 3700 automated sequencer and subcloned using standard techniques into the pSFF retroviral expression vector using the EcoRI restriction site (16) . Mixtures of PA317 and 2 mouse fibroblast cells were transfected with the pSFF plasmid, including the respective wild type or mutant PrP insert and used for protein expression as described previously (9, 17, 18) .
Prokaryotic Protein Expression and Purification-Cells of Escherichia coli BL21(DE3) with the desired PrP construct were grown overnight in 5 ml of NZY liquid culture medium containing 0.05 mg/ml kanamycin. The overnight culture was added to 500 ml of NZY medium with 0.05 mg/ml kanamycin and grown at 37°C in a shaking incubator to an optical density at 600 nm of 0.5. Protein expression was then induced by adding isopropyl-␤-D-thiogalactoside to 0.5 mM to the culture. The induced culture was grown for 2 h at 37°C in a shaking incubator. Cells were then harvested by centrifugation.
Cell pellets were suspended in lysis buffer (50 mM Tris/HCl, pH 7.5, 2 mM EDTA, 0.1% Triton X-100) and sonicated to release the inclusion bodies containing the protein of interest. Inclusion bodies were collected by centrifugation and then solubilized for 2 h in 8 M urea buffered at pH 8 with 0.1 M sodium phosphate and 0.01 M Tris. The solubilized protein solution was then diluted 10-fold with 8.0 M urea in TCB buffer (20 mM Tris/HCl, pH 8.0, 150 mM NaCl, 2.5 mM CaCl 2 ). The solubilized protein solution was purified using Novagen His-Bind resin. The resin was incubated with the solubilized protein in 8 M urea for 2 h. The proteinbound resin was loaded onto the column and washed with a 2 M step gradient from 8 to 0 M urea in TCB. The protein was eluted using 60 mM imidazole in TCB followed by 200 mM imidazole in TCB. Fractions were analyzed using SDS-PAGE to confirm the presence of PrP (molecular mass, 23-kDa). Fractions containing only PrP were pooled and dialyzed against 0.01 M sodium phosphate at pH 6.0 to remove the imidazole and then concentrated using a centrifugal filter device (molecular mass cut-off, 10 kDa) to ϳ0.5 mg/ml final protein concentration (⑀280 ϭ 2.7 ml mg Ϫ1 cm Ϫ1 ). No impurities were seen in the final protein preparations using SDS-PAGE and Coomassie Blue staining. Molecular masses for all purified protein constructs were confirmed using MALDI mass spectrometry. The molecular masses for the D144N, D147N, and D144N/D147N mutants were 0.95, 0.82, and 1.89 atomic mass units lower, respectively, than the wild type protein, consistent with the respective theoretical molecular masses.
Circular Dichroism Spectroscopy and Denaturation Curves-Circular Dichroism (CD) spectroscopy was performed using an On-line Instrument Systems (Olis) CD module with a Cary-16 spectrophotometer conversion unit with a NESLAB RTE-111 temperature control module. For thermal denaturation experiments the ellipticity from 225 to 207.5 nm of PrP samples at 0.3 mg/ml in 0.01 M NaPO 4 at pH 6.0 was measured at intervals between 25 and 72.5°C. Full spectra at 25, 62.5, and 72.5°C were scanned from 185 to 260 nm. Samples were scanned three times with a 0.5-nm scanning interval in a 1.0-mm cylindrical cell after equilibrating 15 min at the desired temperature. Scans were averaged using the Olis spectral processing software supplied with the instrument. The fraction of unfolded protein for each construct was determined using the molar ellipticity at 222 nm and was plotted versus the temperature in degrees Celsius. The ellipticity at 72.5°C was used for the unfolded protein ellipticity. All of the mutant protein signals were normalized to the wild type PrP unfolded signal. Averages and standard deviations of transition midpoints and slopes were determined from three individual experiments for each protein.
For the GdnHCl denaturation experiments, samples from 0 to 5.0 M GdnHCl were prepared by diluting a stock PrP solution (0.3 mg/ml) with varying amounts of a stock 8.0 M GdnHCl solution and buffer giving a final protein concentration of 0.1 mg/ml. All solutions were buffered at pH 6.0 in 0.01 M NaPO 4 . Samples were allowed to equilibrate for at least 1 h prior to analysis. Samples were scanned three times in a 1.0-mm cylindrical cell from 225 to 207.5 nm with a 0.5-nm scanning interval at 25°C. All spectral data were corrected for absorbance by the buffer and denaturant. The fraction of unfolded protein was determined for each construct using the ellipticity at 222 nm. Averages and ranges for the thermodynamic parameters were determined from two individual experiments for each protein. Thermal and GdnHCl denaturation curves were fit using the non-linear regression analysis tool on GraphPad Prism. Thermal unfolding transition midpoints and GdnHCl denaturation thermodynamic parameters were determined assuming a two-state unfolding process as described by Pace and Scholtz (19 (20 -22) . Lysis and extraction of PrP from cells was then performed as described previously (23, 24) . The protein was immunoprecipitated using the mouse 3F4 monoclonal antibody as described previously (24) .
Cell-free Conversion Reaction-PrP-res from 263K scrapie-infected hamsters was prepared using a revision of the Bolton et al. method (25) and was stored in 0.5% sulfobetaine (Calbiochem, La Jolla, CA, Zwittergent 3-14) in phosphate-buffered saline as described previously (9, 20) . Crude normal and 263K-infected hamster brain microsomes were prepared as described previously (26) . Two different cell-free reaction conditions were used: 1) reactions using purified PrP-res pretreated with 2 M GdnHCl for 1 h at 37°C and 2) reactions using PrP-res in brain microsomes. Cell-free conversion reactions in the presence of GdnHCl using purified PrP-res and reactions without detergents and denaturants using microsomal PrP-res were performed as described previously (9, 21, 24, 26) . Each reaction contained 100 ng of 263K PrP-res mixed with 10,000 to 20,000 cpm of [
35 S]PrP-sen. For reactions using GdnHCl pretreated PrP-res final reaction mixtures also contained 364 mM GdnHCl, 34 mM Sarkosyl, 1.25 mM sulfabetaine, 5 nM hexadecylpyridinium chloride, and 50 mM sodium citrate at pH 6.0. For conversions using microsomal PrP-res, final reaction mixtures also contained 100 mM NaCl, 5 mM MgCl 2 , and 50 mM sodium citrate at pH 6.0. Reactions were incubated for 40 -48 h at 37°C. After incubation, 90% of the reaction mixture was treated with 20 g/ml PK at 37°C for 1 h. The remaining 10% was analyzed without PK treatment. The PK digestion was stopped by adding Pefabloc (Roche Molecular Biochemicals) to 2 mM, 20 g of thyroglobulin as a carrier protein, and four volumes of methanol. Precipitated proteins were collected by centrifugation and separated by SDS-PAGE using Novex NuPAGE pre-cast polyacrylamide gels. Radioactive proteins were visualized and quantified using a PhosphorImager (Amersham Biosciences).
RESULTS
Disulfide Bond Formation and Protein Purity-To investigate the roles of the helix 1 Asp residues and their proposed salt bridges on the stability of the secondary structure of PrP, three mutant proteins (D144N, D147N, and D144N/D147N) of full-length hamster PrP (residues 23-231) were expressed as cytoplasmic inclusion bodies in Escherichia coli, purified, and refolded for analysis by circular dichroism spectroscopy. The purified proteins were analyzed by SDS-PAGE to assess protein purity and the presence of the disulfide bond between Cys179 and Cys 214 (Fig. 2) . The slower migration of the proteins on SDS-PAGE upon treatment with ␤-mercaptoethanol (lanes 1-4) than untreated samples (lanes 5-8) indicated that the disulfide bond was present in the untreated preparations of each construct (27) . Each protein ran as a single band with an estimated purity of at least 90%.
Thermal Denaturation Monitored by CD Spectroscopy-The secondary structures and stabilities of the PrP mutants relative to wild type PrP were assessed by CD spectroscopy. Under non-denaturing conditions at 25°C and pH 6.0 (the optimal pH for most PrP-res-induced cell-free conversion reactions), spectra of the wild type and mutant PrP constructs (Fig. 3a) were identical, each showing negative lobes at 208 and 222 nm indicative of highly ␣-helical secondary structures as has been seen previously for PrP-sen derived from brain (6), mammalian tissue culture cells (28) , and recombinant PrP synthesized and refolded from inclusion bodies (29) . These data suggest the Asp residues and their respective salt bridges do not substantially stabilize helix 1. Thermal denaturation was performed to determine if the mutants were destabilized with respect to secondary structure and unfolding transitions. The thermal denaturation curves were sigmoidal for all constructs, suggesting that they undergo a two-state unfolding transition (Fig. 3b) . However, none of the thermal unfolding reactions for the PrP constructs were reversible; thus, thermodynamic values could not be obtained. Transition midpoints and slopes of the unfolding transition regions were used for comparison instead. The transition midpoints (Table I) for the mutants were within 2.2°C of the wild type protein transition midpoint suggesting that the PrP secondary structure is not substantially destabilized by the mutations and the presumed elimination of the helix 1 salt bridges. However, the slopes of the transition regions of the mutant unfolding curves (Table I) were lower than the slope of the wild type protein unfolding curve. These data indicate that the mutants unfold differently and less cooperatively than the wild type protein.
To look more closely at the thermal denaturation differences between the wild type and mutant PrP molecules, CD spectra at 62.5°C, 72.5°C, and, 25°C after cooling from 72.5°C, were overlaid (Fig. 3, c-e) . The wild type protein changed from a highly ␣-helical conformation at 25°C (Fig. 3a) to a highly ␤-sheet conformation at 62.5 and 72.5°C as indicated by the negative peak centered at 215 nm (Fig. 3, c and d) . At 62.5°C all three mutants appeared to still have some ␣-helical content judging by the slight negative dips in ellipticity at 208 and 222 nm (Fig. 3c) . At 72.5°C the mutant spectra all had negative lobes around 204 nm different from the wild type spectrum, most noticeable in the D144N and D144N/D147N mutant spectra (Fig. 3d) . This difference indicated that the mutant proteins have different states of denaturation at 72.5°C than the wild type. Negative ellipticities below 200 nm are associated with disordered structure; thus, the mutant PrP conformations appeared to contain more disordered structure than the more ␤-sheet-containing wild type protein. In addition to the conformational differences at 72.5°C, there were differences in the reversibilities of the unfolding induced by this temperature. Thermal denaturation of the wild type protein was highly irreversible, which has been shown previously (30) , as can be seen by the fact that the spectra at 72.5 and 25°C after cooling from 72.5°C are shaped similarly with main negative lobes for both spectra centered close to 215 nm (Fig. 3, d and e) . Spectra of the mutant PrP molecules after cooling from 72.5°C to 25°C showed a partial change back to more ␣-helical spectra with the D144N and D144N/D147N spectra, in particular, showing negative lobes at 208 and 222 nm (Fig. 3e) , which are similar to, but not identical to the spectra at 25°C prior to thermal denaturation (Fig. 3a) . These data suggest the mutant proteins unfold to a different denatured state structure at 72.5°C than the wild type protein.
GdnHCl Denaturation Monitored by CD Spectroscopy-To further investigate the unfolding of the PrP helix 1 mutants, GdnHCl unfolded samples of wild type D144N, D147N, and D144N/D147N PrP at pH 6.0 were monitored using CD spectroscopy at 222 nm. As shown in Fig. 4 , the sigmoid shapes of the unfolding curves indicated that all the constructs underwent a cooperative two-state transition. All unfolding reactions were found to be reversible (data not shown). Thermodynamic parameters, determined from the unfolding data assuming a two-state transition, are shown in Table I . The wild type protein had a free energy of conformation ((⌬G(H 2 O)) similar to that for recombinant full-length ovine PrP (27) but lower than that reported for full-length murine PrP (14) . Table I . c-e, far-UV CD spectra of samples containing wild type, D144N, D147N, and D144N/D147N hamster PrP-sen (residues 23-231) at 62.5°C, 72.5°C, and 25°C after cooling from 72.5°C, respectively. Spectral colors are the same as in a. In e the wild type PrP spectrum at 25°C (ϩ) is included for comparison. Protein concentrations for all samples were 0.3 mg/ml. Cell-free Conversion-It remained to be determined whether the helix 1 aspartic acid residues are involved in the interactions necessary for the conversion of PrP-sen to PrP-res. Specifically, if the critical interaction required for the conversion involved intermolecular ionic bonds between aspartic acid (Asp-144 and Asp-147) and arginine (Arg-148 and Arg-151) residues as proposed (12) , one would expect conversion of the mutants lacking the Asp residues to be inhibited. To address this question the D144N, D147N, and D144N/D147N PrP mutants were expressed in mammalian cells, radiolabeled using [ 35 S]methionine, and analyzed using the cell-free conversion assay (9) . The assay is performed by "seeding" the conversion of 35 S-labeled PrP-sen using PrP-res from the brains of hamsters infected with 263K scrapie. After an incubation period, newly converted (radiolabeled), partially protease-resistant PrP is detected following digestion with proteinase K by SDS-PAGE and phosphor autoradiography (9, 10). We limited the conversion reactions to PrP-sen that was metabolically radiolabeled in mammalian cells because of difficulties in generating [ 35 S]methionine labeled PrP-sen with sufficient specific activity when expressed in E. coli. Fig. 5 shows the results of conversion reactions performed in the presence of detergents and GdnHCl using purified 263K hamster PrP-res to drive the reaction. Fig.  5a shows the undigested radiolabeled PrP post-incubation without (lanes 1-4) and with (lanes 5-8) PrP-res. Lanes 9 -16 show the remaining portion of the same samples after a 1-h digestion with PK. The lanes incubated without PrP-res had no protease-resistant bands. However, samples incubated in the presence of PrP-res showed distinct protease-resistant 35 S-PrP bands that, like PK digestion products of brain-derived PrP-res itself, were 6 -7 kDa lower in molecular mass than full-length precursor 35 S-PrP-sen molecules. Quantification of the proportion of the input 35 S-PrP-sen converted to PK-resistant bands of 19 -26 kDa (i.e. conversion efficiency) is shown in Fig. 5b . In this case all three mutants converted (lanes 14 -16) with statistically indistinguishable efficiencies from the wild type PrP control (lane 13). These data are not consistent with the previously observed conversion inhibition of PrP helix 1 deletion mutants (31) , suggesting that aspartic acid residues 144 and 147 are not essential for the conversion of PrP-sen to PrP-res in the presence of detergents and GdnHCl.
Because the above conversion conditions (especially the presence of GdnHCl) may have blocked the ionic interactions necessary for the presence of the helix 1 salt bridges, conversion reactions were performed without detergents or denaturants as described recently (10) . This method uses a crude scrapie brain microsome fraction containing PrP-res to drive conversion. These conversion reactions more closely mimic conditions found on cell membranes where PrP-sen is located and most likely converted in scrapie-infected cells (23, 32) . Under these conditions, the PrP mutants converted with two-three times the conversion efficiency as the wild type PrP (Fig. 6, a and b) . Thus, the replacement of the aspartic acid residues with asparagines at positions 144 and 147 enhanced, rather than prevented, conversion to PrP-res.
The influence of the helix 1 salt bridges on PrP conversion was also tested using 35 S-labeled PrP-sen mutants where the aspartic acids at positions 144 and 147 were individually or both replaced with alanines. These replacements should have prevented ion-dipole interactions in addition to ion-ion interactions between the side chains of the residues involved in the helix 1 salt bridges in wild type PrP. If the increases in conversion efficiencies of the D-to-N PrP mutants were solely due to the loss of a salt bridge or any other interaction that stabi- FIG. 4 . GdnHCl denaturation of wild type PrP and helix 1 PrP mutants. The fraction unfolded was determined using the CD ellipticities at 222 nm. Data were fitted and analyzed assuming a two-state transition. Thermodynamic parameters are listed in Table I . All samples contained 0.1 mg/ml PrP. The samples were incubated at least 1 h prior to taking the CD spectra. All samples were prepared in 10 mM NaPO 4 buffer at pH 6.0. Data labels are the same as in Fig. 3b . lizes the native ␣-helical structure from converting to PrP-res, then one would expect that the D-to-A mutant proteins would show the same conversion behavior as the respective D-to-N mutants. Using radiolabeled D144A, D147A, and D144A/ D147A PrP-sen mutants in the detergent and GdnHCl-free conversion reactions, we produced the expected conversion products (Fig. 7a, compare lanes 9 -16 to lanes 1-8) . The conversion efficiencies of the D-to-A mutant PrP constructs were roughly three to four times as efficient as the conversion efficiency of the wild type PrP (Fig. 7b) , confirming that mutations expected to disrupt the helix 1 salt bridges promote PrP-resinduced conversion. The fact that D-to-A mutants were even more efficiently converted than the D-to-N mutants suggests that, in the latter, some stabilizing interactions between the Asn-144, Asn-147, and the arginines in helix 1 (presumably ion-dipole interactions) still occur.
DISCUSSION
This investigation sought to determine the role of the putative Asp-Arg helix 1 salt bridges in the stability of PrP-sen and whether the same residues proposed to be involved in the salt bridges play a role in the conversion of PrP-sen to PrP-res. It appears from our data that helix 1 does not behave as has been previously proposed (12) . That is, our data suggest that the helix 1 salt bridges do not substantially stabilize PrP under native conditions, and, intermolecular salt bridge formation between the same salt bridge residues is not critical for the conversion of PrP-sen to PrP-res. Instead it appears that the aspartic acid residues affect how the protein unfolds and provide stability against the conversion of PrP-sen to PrP-res.
The contribution of surface salt bridges, such as those proposed to exist on helix 1, has generally been considered to contribute little to the overall stability of protein structures. It has been reported that salt bridges buried in the protein interior contribute as much as 20.9 kJ/mol, whereas surface salt bridges contribute only 2.1-5.0 kJ/mol to protein-free energies of conformation (33, 34) . Our data are consistent with this consensus, because the Gibbs free energies of conformation of the D144N, D147N, and D144N/D147N mutants were estimated by GdnHCl unfolding to be only 2.3, 0.9, and 5.1 kJ/mol lower, respectively, than wild type hamster PrP-sen. These data, combined with the fact the CD spectra of the mutants are identical to the wild type protein at 25°C, suggest that there is no unusual stability gain due to ionic interactions involving the aspartic acid and arginine residues of helix 1 of hamster PrP-sen.
Although the effects of the helix 1 mutations on the overall free energy of PrP are modest, the localized effects on helix 1 stability might be more dramatic. At pH levels below 4.0, three-state unfolding transitions have been reported for recombinant human PrP in the presence of GdnHCl and urea with salt (30, 35) . It is tempting to think that the first transition might involve the unfolding of a localized domain containing helix 1, because this helix has been modeled to lose helical structure at low pH (36) and has been shown to more easily undergo hydrogen-deuterium exchange than the central portions of helices 2 and 3 (37), suggesting a looser, less compact structure that might unfold more readily. Such a transition at low pH might be dependent on the protonation and ionic screening of the aspartic acids disrupting the salt bridges leading to the unfolding of helix 1 prior to the unfolding of the remaining helices. If such a three-state transition were occurring under the conditions of our experiments (i.e. pH 6), one might expect to have detected it in our unfolding curves monitored at 222 nm, because helix 1 makes up 18% of the total helix content of PrP-sen. However, our unfolding curves of both the wild type and helix 1 mutants suggested only two-state processes without any additional inflection points. Nonetheless, the helix 1 mutations reduced the slopes of the transition regions for the thermal denaturation curves, indicating the mutants unfold less cooperatively than the wild type protein. This effect was especially apparent for the D144N/D147N double mutant. Presumably, therefore, replacement of the helix 1 aspartates destabilizes helix 1 to some extent, but our data provide no evidence that this allows helix 1 to unfold independently of the other helices under the conditions suitable for the PrP-res-induced conversion reaction. One possibility is that helix 1 is already partially unfolded under these conditions, reducing our chances of detecting any independent unfolding in the denaturation curves. In any case, the low structural resolution of CD spectroscopy prevents us from fully discerning the conformational effects of the aspartate replacement and elimination of putative helix 1 salt bridges.
The differences between unfolding cooperativities of the mutant and wild type PrP molecules raise the possibility that the helix 1 aspartic acids are involved with stabilizing interactions other than the intra-molecular salt bridges. Eleven different salt bridges involving seven different anionic residues and eight different cationic residues were predicted in molecular dynamic simulations of human and Syrian hamster PrP-sen as reported by Zuegg and Gready (38) . Five of the eleven proposed salt bridges involve either Asp-144 or Asp-147, including, in addition to the intra-helix salt bridges investigated here, Asp-144 with His-140, Asp-144 with Arg-208, and Asp-147 with His-140. The differences in unfolding cooperativities could result from the elimination of any of the five proposed salt bridges.
Protein unfolding cooperativity differences can also result from differences in the stabilities of the denatured state conformations (33, 39) . The PrP thermal denaturation data show that the denatured states of the mutants at 72.5°C differ from the wild type protein suggesting the mutants unfold via somewhat different conformations. Such alterations in the unfolding pathway, rather than differences in overall thermodynamic stability, could account for the increased conversion efficiencies seen in our cell-free conversion experiments. Consistent with this possibility are observations that decreased thermodynamic stability of PrP C is not a common characteristic of mutants associated with familial Creutzfeldt-Jakob disease, Gerstmann-Strä ussler-Scheinker syndrome, and fatal familial insomnia (40, 41) . Reasons proposed for how mutations associated with inherited forms of spongiform encephalopathies lead to disease include: (a) an increase in the stability of PrP Sc ; (b) an increased fraction of alternative conformations in equilibrium with PrP C , which may act as precursors to PrP Sc ; and (c) differences in PrP C folding kinetics with accumulation of PrP Sclike kinetic folding intermediates (41) . Any of these reasons could apply as reasons for the increase in PrP-res formation seen in the cell-free conversion reactions using microsomal PrP-res and the PrP-sen helix 1 mutants studied herein.
Thus, the helix 1 mutants may populate more convertible conformations along the PrP-sen to PrP-res conversion pathway to a greater extent than wild type PrP. Alternatively, because the helix 1 mutants do not unfold to the same ␤-sheetcontaining denatured structures at 62.5 and 72.5°C as the wild type protein, it is possible that the mutants populate an offpathway ␤-sheet conformation to a lesser extent than the wild type protein. The formation of an off-pathway ␤-oligomer has been previously reported to occur during amyloid fibril formation of recombinant PrP 27-30 (42) .
The more disordered conformations seen with the helix 1 mutants during thermal denaturation might be more convertible to PrP-res than the more ␤-sheet conformation of wild type PrP. However, Rezaei et al. (43) recently reported that the thermally denatured conformations of ovine PrP variants associated with low susceptibility to scrapie infection contained more disordered structure, whereas the highly susceptible variants contained more ␤-sheet. The ovine PrP variant data is not consistent with our data, because our mutants show more disordered structure but convert with higher efficiencies relative to the wild type protein. Thus, it appears that unfolding to a more disordered conformation is not necessarily associated with increased susceptibility to PrP-res formation. Rather, our data suggest that our D-to-N mutants populate intermediate conformations that contain unspecified secondary structures with less ␤-sheet that are more susceptible to PrP-res formation than wild type PrP.
Considering all the data, three mechanistic pathways leading to PrP-res formation can be proposed assuming the conversion is based on the autocatalytic seeded polymerization model (40, 44, 45) (Fig. 8) . Assuming PrP-sen is in equilibrium with convertible, intermediate, and non-convertible conformations, the pathways vary depending on which conformation binds to PrP-res. In pathway a, the intermediate PrP-sen conformation binds to PrP-res. After binding, the PrP-sen molecule can undergo a conformational transition to either the convertible conformation or to the off-pathway non-convertible conformation. PrP-res is only formed when the bound PrP-sen molecule attains the convertible conformation. In pathway b, convertible FIG. 8 . Theoretical mechanistic model for the conversion of PrP-sen to PrP-res. Assuming that conversion follows the autocatalytic seeded polymerization model (40, 44) three pathways leading to conversion are proposed. With all pathways, unbound PrP-sen is in equilibrium with convertible, intermediate, and non-convertible conformations. In pathway a, after binding to PrP-res, intermediate PrP-sen undergoes a conformational transition to either a convertible conformation that can subsequently convert to PrP-res or a non-convertible, off-pathway conformation that cannot convert to PrP-res without returning to the intermediate conformation or unbinding. In pathway b, the convertible PrP-sen molecule binds to PrP-res where it can then directly convert to PrP-res. In pathway c, the non-convertible PrP-sen binds to PrP-res in an off pathway manner. PrP-res can only be formed if the bound PrP-sen converts to the convertible PrP-sen conformation by passing through the intermediate conformation or through rebinding in a different conformation. In this model the helix 1 mutant PrP molecules populate the convertible conformation along pathways a and b, avoiding the non-convertible pathway to a greater extent than the wild type protein and, thus, having higher conversion efficiencies in the cell-free conversion assay.
PrP-sen binds to PrP-res and then can convert directly to PrP-res. In pathway c, a non-convertible PrP-sen conformer binds to PrP-res and must transform to intermediate and/or convertible PrP-sen prior to converting to PrP-res. Evidence for the existence of bound, but non-convertible states has come from previous studies of interspecies conversion reactions (46) . In the case of the helix 1 mutants, PrP-sen is proposed to be less likely to adopt the non-convertible conformation resulting in more conversion of the mutant PrP-sen molecules to PrP-res than the wild type PrP-sen.
In summary, these results suggest that PrP-sen is not substantially stabilized by the aspartic acid-arginine salt bridges. However, the helix 1 mutants unfold less cooperatively and do not attain the same ␤-sheet denatured state as the wild type protein upon thermal denaturation. Cell-free conversion data suggest the salt bridge residues are not critical for the formation of PrP-res, because protease-resistant material was generated in all conversion reactions performed with and without the presence of detergents and denaturants. The conversion efficiencies of the mutants in the absence of detergents and denaturants, conditions favorable to salt bridge formation, are higher than the wild type protein, indicating that the elimination of the anionic charge of the aspartic acids increases the convertibility of PrP-sen. The increase in conversion could possibly be due to the elimination of an off-pathway conformation along the conformational pathway leading to conversion to PrP-res.
